The Europe electrophysiology market is expected to grow from US$ 2,398.85 million in 2022 to US$ 4,234.94 million by 2028; it is estimated to grow at a CAGR of 9.9% from 2022 to 2028.
According to the World Health Organization (WHO), cardiovascular disease (CVD) is one of the leading causes of death across the region. Family history, ethnicity, age, tobacco use, high blood pressure (hypertension), high cholesterol, lack of exercise, unhealthy diet, alcohol consumption, and diseases such as dyslipidemia, obesity, and diabetes are contributing to the rising incidence of CVD, such as stroke. Atrial fibrillation (AF) is the most commonly diagnosed arrhythmia in clinical practice, affecting over ~886,000 new people in Europe each year. According to the US Census Bureau report on the burden of atrial fibrillation, Europe is expected to register the highest number of patients with AF by 2050. So, the rising number of incidences of target diseases and procedures is expected to drive the market growth.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe electrophysiology market at a substantial CAGR during the forecast period.
The Europe electrophysiology market is segmented based on product, indication, and country. Based on product, the market is segmented into electrophysiology ablation catheters, electrophysiology laboratory devices, electrophysiology diagnostic catheters, access devices, and others. The electrophysiology laboratory devices segment dominated the market in 2022 and electrophysiology ablation catheters segment is expected to be fastest growing during forecast period. Based on indication, the market is segmented into atrial fibrillation (AF), atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), wolff-parkinson-white syndrome (WPW), and others. The atrial fibrillation (AF) segment dominated the market in 2022 and is expected to be fastest growing during forecast period. Based on country, the Europe electrophysiology market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe.
Abbott; Biotronik, Inc.; Boston Scientific Corporation; CardioFocus; GE Healthcare; Johnson & Johnson Services, Inc.; Koninklijke Philips N.V.; Medtronic; MicroPort Scientific Corporation; and Siemens Healthineers AG are among the leading companies operating in the Europe electrophysiology market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 2,398.85 Million |
| Market Size by 2028 | US$ 4,234.94 Million |
| CAGR (2022 - 2028) | 9.9% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Electrophysiology Market is valued at US$ 2,398.85 Million in 2022, it is projected to reach US$ 4,234.94 Million by 2028.
As per our report Europe Electrophysiology Market, the market size is valued at US$ 2,398.85 Million in 2022, projecting it to reach US$ 4,234.94 Million by 2028. This translates to a CAGR of approximately 9.9% during the forecast period.
The Europe Electrophysiology Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Electrophysiology Market report:
The Europe Electrophysiology Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Electrophysiology Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Electrophysiology Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)